# Safety and Efficacy of DCB for the Treatment of SFA Ischemic Vascular Disease in Patients With TASC C and D Lesions

> **NCT03129750** · — · UNKNOWN · sponsor: **Ettore Sansavini Health Science Foundation** · enrollment: 150 (estimated)

## Conditions studied

- PAD

## Interventions

- **DEVICE:** Drug Coated Balloon

## Key facts

- **NCT ID:** NCT03129750
- **Lead sponsor:** Ettore Sansavini Health Science Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2017-09
- **Final completion:** 2020-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03129750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03129750, "Safety and Efficacy of DCB for the Treatment of SFA Ischemic Vascular Disease in Patients With TASC C and D Lesions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03129750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*